Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1NET 1Endocrine 1Dermatologic 1CNS 1

Conditions

Neoplasms 271Breast Neoplasms 264Lung Neoplasms 130Prostatic Neoplasms 114Colorectal Neoplasms 108Carcinoma, Non-Small-Cell Lung 103Pancreatic Neoplasms 67Carcinoma, Hepatocellular 53Ovarian Neoplasms 51Stomach Neoplasms 49Multiple Myeloma 49Hematologic Neoplasms 49Urinary Bladder Neoplasms 47Brain Neoplasms 45Melanoma 42Leukemia, Myeloid, Acute 42Head and Neck Neoplasms 40Esophageal Neoplasms 40Colonic Neoplasms 38Disease 37Liver Neoplasms 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Rectal Neoplasms 34Lymphoma 32Neoplasm Metastasis 31Leukemia, Lymphocytic, Chronic, B-Cell 30Endometrial Neoplasms 30Recurrence 28Kidney Neoplasms 28Uterine Cervical Neoplasms 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Vipoma × 90 days × Clear all
NCT03583528 2026-05-12

DOTATOC PET/CT for Imaging NET Patients

British Columbia Cancer Agency

Active not recruiting
800 enrolled
CNSDermatologicEndocrineNETThoracic

Carcinoid Tumor, Vipoma, Ganglioneuroma, Glucagonoma, Insulinoma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡